Shah told CNBC-TV18, "In Max India, the MD himself buying shares of the company very aggressively and this is what we had mentioned a couple of times. The company has got this insurance subsidiary and they are holding about 75% in it and the value of that is said to be more than the parent company that is Max India. Despite holding a substantial stake in the company the MD has been buying the shares very aggressively through creeping acquisitions, so it gives us the confidence that the company is in for good times, the stock is at Rs 225 and our target is Rs 275."